Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 7 Colorectal Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Colonic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Primary Ovarian Insufficiency 1 Polycystic Ovary Syndrome 1 Pheochromocytoma 1 Pediatric Solid Tumor 1 Paraganglioma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphangioleiomyomatosis 1 Lipodystrophy, Familial Partial 1 Kidney Neoplasms 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Genetic Testing × 1 year × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡